Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion

Diabetologia
T TomitaK Nakao

Abstract

G protein-coupled receptor 40 (GPR40) is abundantly expressed in pancreatic beta cells in rodents, where it facilitates glucose-induced insulin secretion in response to mid- to long-chain fatty acids in vitro. However, GPR40 gene expression in humans has not been fully investigated, and little is known about the physiological and pathophysiological roles of GPR40 in humans. The aim of this study, therefore, was to examine GPR40 expression and its clinical implications in humans. GPR40 mRNA expression in the human pancreas, pancreatic islets and islet cell tumours was analysed using TaqMan PCR. GPR40 mRNA was detected in all human pancreases collected intraoperatively. It was enriched approximately 20-fold in isolated islets freshly prepared from the pancreases of the same individuals. The estimated mRNA copy number for the GPR40 gene in pancreatic islets was comparable to those for genes encoding sulfonylurea receptor 1, glucagon-like peptide 1 receptor and somatostatin receptors, all of which are known to be expressed abundantly in the human pancreatic islet. A large amount of GPR40 mRNA was detected in insulinoma tissues, whereas mRNA expression was undetectable in glucagonoma or gastrinoma. The GPR40 mRNA level in the pancre...Continue Reading

References

Jul 1, 1997·Prostaglandins, Leukotrienes, and Essential Fatty Acids·E A Nunez
Oct 21, 1998·Journal of Cellular Biochemistry·G GiannacciniC Martini
Mar 4, 1999·Diabetologia·J D McGarry, R L Dobbins
Mar 18, 2000·The Journal of Nutrition·B E CorkeyM Prentki
Nov 5, 2002·The Journal of Clinical Endocrinology and Metabolism·Hiroshi IwakuraKazuwa Nakao
Dec 24, 2002·The Journal of Biological Chemistry·Celia P BriscoeAlison I Muir
Feb 5, 2003·Biochemical and Biophysical Research Communications·Knut KotarskyBjörn Olde
Apr 10, 2003·Biochemical and Biophysical Research Communications·Niclas E NilssonBjörn Olde
Jun 24, 2003·Diabetologia·F M Gribble, F Reimann
Jan 27, 2004·Biochemical and Biophysical Research Communications·T YonezawaY Obara
May 8, 2004·Metabolism: Clinical and Experimental·Akiko Takahashi-YasunoKazuwa Nakao
Oct 16, 2004·The Journal of Clinical Endocrinology and Metabolism·Ele FerranniniRalph A DeFronzo
Dec 21, 2004·Diabetic Medicine : a Journal of the British Diabetic Association·Y H HamidT Hansen
Dec 28, 2004·Nature Medicine·Akira HirasawaGozoh Tsujimoto
Feb 8, 2005·The Journal of Biological Chemistry·Serge HardyMarc Prentki
Feb 11, 2005·The Journal of Biological Chemistry·Hiroshi IwakuraKazuwa Nakao
Mar 1, 2005·Metabolism: Clinical and Experimental·Takeo OgawaTakao Saruta

❮ Previous
Next ❯

Citations

Jul 14, 2012·Nature Reviews. Drug Discovery·Clara C BladStefan Offermanns
Aug 2, 2010·Journal of Diabetes Investigation·Takeshi Ogihara, Raghavendra G Mirmira
Nov 8, 2007·PloS One·Martins KalisCorrado M Cilio
Oct 29, 2013·Annual Review of Pharmacology and Toxicology·Stefan Offermanns
Mar 29, 2014·The Journal of Endocrinology·Philip NewsholmeKevin Keane
Jun 29, 2014·Journal of Pharmaceutical and Biomedical Analysis·Xiaofang HouLangchong He
May 1, 2007·Expert Opinion on Therapeutic Targets·Geetha Vani RayasamVinay S Bansal
Jun 15, 2011·Trends in Pharmacological Sciences·Saswata TalukdarOlivia Osborn
Oct 5, 2010·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiaodong ZhangHeyao Wang
Oct 10, 2009·Molecular and Cellular Endocrinology·Ming YangJohn C Shryock
Sep 29, 2007·Pharmacology & Therapeutics·Maria Sörhede Winzell, Bo Ahrén
Jan 24, 2007·Bioorganic & Medicinal Chemistry Letters·Stephen C McKeownDeirdre M B Hickey
Jan 22, 2013·Diabetes, Obesity & Metabolism·K Matsuda-NagasumiY Kaisho
Mar 5, 2014·BioFactors·Robin M TuckerCordelia A Running
Jan 22, 2015·Diabetes, Obesity & Metabolism·A D Mancini, V Poitout
Aug 19, 2015·Biochemical and Biophysical Research Communications·Kaori FukushimaToshifumi Tsujiuchi
Feb 25, 2015·Nature Reviews. Endocrinology·Sara Santa-Cruz Calvo, Josephine M Egan
Oct 14, 2014·Frontiers in Endocrinology·Tsutomu TomitaKazuwa Nakao
Jun 15, 2016·Chemical Reviews·Graeme MilliganBrian D Hudson
Nov 3, 2016·Molecular Pharmacology·J M Houthuijzen
Dec 26, 2017·Acta Histochemica Et Cytochemica·Sharmin AktarToyoshi Fujimoto
Apr 3, 2019·Annals of the New York Academy of Sciences·Yumi ImaiJoseph A Promes
Nov 29, 2008·Cancer Science·R J A FijnemanR T Cormier
Sep 17, 2013·Endocrinology·Hjalti KristinssonErnest Sargsyan
Nov 30, 2006·Clinical Science·Philip NewsholmeNoel G Morgan
Nov 30, 2006·Diabetes·Christopher J NolanMarc Prentki
Jan 27, 2021·Nature Reviews. Endocrinology·Julien Ghislain, Vincent Poitout

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.